SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
Good ACE, bad ACE do battle in lung injury, SARS | Nature Medicine
The Renin–Angiotensin System: The Good, the Bad, and the Ugly - Anesthesiology News
Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19 | Hypertension Research
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent | Hypertension
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities | eLife
ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the
A review on SARS-CoV-2 and stroke pathogenesis and outcome | The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Full Text
Cancers | Free Full-Text | Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 | NEJM
ACE2 and COVID-19 and the resulting ARDS | Postgraduate Medical Journal
Frontiers | ACE2, Much More Than Just a Receptor for SARS-COV-2
Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD - ScienceDirect
Tissue ACE phenotyping in lung cancer | PLOS ONE
Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers - Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima ...
View of The regulation of ACE-2 in the heart and lungs | The Southwest Respiratory and Critical Care Chronicles
Cancers | Free Full-Text | SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells | The EMBO Journal
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions
A decoy mutant ACE2 designed to reduce COVID-19: Trends in Pharmacological Sciences
Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment - ScienceDirect
The protein expression profile of ACE2 in human tissues | Molecular Systems Biology
